Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. from 31 Dec 2015 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Dec 2015 to 30 Sep 2024.
  • THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2024 was $1,681,713, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,681,713 +$372,023 +28% 30 Sep 2024 10-Q 20 Nov 2024 2024 Q3
Q2 2024 $1,835,803 +$344,257 +23% 30 Jun 2024 10-Q 20 Nov 2024 2024 Q3
Q1 2024 $2,005,375 +$839,930 +72% 31 Mar 2024 10-Q 19 Aug 2024 2024 Q2
Q4 2023 $1,281,882 -$103,299 -7.5% 31 Dec 2023 10-Q 20 Nov 2024 2024 Q3
Q3 2023 $1,309,690 -$473,985 -27% 30 Sep 2023 10-Q 20 Nov 2024 2024 Q3
Q2 2023 $1,491,546 -$720,894 -33% 30 Jun 2023 10-Q 20 Nov 2024 2024 Q3
Q1 2023 $1,165,445 -$1,139,584 -49% 31 Mar 2023 10-Q 19 Aug 2024 2024 Q2
Q4 2022 $1,385,181 +$1,989,521 31 Dec 2022 10-Q 20 Nov 2024 2024 Q3
Q3 2022 $1,783,675 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $2,212,440 30 Jun 2022 10-Q 14 Nov 2023 2023 Q3
Q1 2022 $2,305,029 +$3,820,052 31 Mar 2022 10-Q 21 Aug 2023 2023 Q2
Q4 2021 $604,340 +$1,173,759 +66% 31 Dec 2021 10-K 17 Apr 2024 2023 FY
Q1 2021 $1,515,023 +$422,929 +22% 31 Mar 2021 10-Q/A 21 May 2021 2021 Q1
Q4 2020 $1,778,099 +$256,945 +13% 31 Dec 2020 10-Q/A 21 May 2021 2021 Q1
Q3 2020 $1,395,998 +$236,366 +14% 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 $1,738,868 -$254,872 -17% 30 Jun 2020 10-Q 17 Nov 2020 2020 Q3
Q1 2020 $1,937,952 -$237,358 -14% 31 Mar 2020 10-Q/A 21 May 2021 2021 Q1
Q4 2019 $2,035,044 -$224,576 -12% 31 Dec 2019 10-Q/A 21 May 2021 2021 Q1
Q3 2019 $1,632,364 -$159,686 -11% 30 Sep 2019 10-Q 17 Nov 2020 2020 Q3
Q2 2019 $1,483,996 +$264,759 +15% 30 Jun 2019 10-Q 17 Nov 2020 2020 Q3
Q1 2019 $1,700,594 -$329,729 -24% 31 Mar 2019 10-Q/A 24 Aug 2020 2020 Q2
Q4 2018 $1,810,468 -$496,114 -38% 31 Dec 2018 10-K/A 12 Apr 2021 2020 FY
Q3 2018 $1,472,678 -$379,473 -35% 30 Sep 2018 10-Q 20 Nov 2019 2019 Q3
Q2 2018 $1,748,755 -$850,813 -95% 30 Jun 2018 10-Q 20 Nov 2019 2019 Q3
Q1 2018 $1,370,865 -$630,083 -85% 31 Mar 2018 10-Q 20 May 2019 2019 Q1
Q4 2017 $1,314,354 -$659,522 -101% 31 Dec 2017 10-K 21 May 2020 2019 FY
Q3 2017 $1,093,205 30 Sep 2017 10-Q 16 Nov 2017 2017 Q3
Q2 2017 $897,942 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $740,782 31 Mar 2017 10-Q 05 Jul 2017 2017 Q1
Q4 2016 $654,832 -$425,804 -186% 31 Dec 2016 10-K 15 Apr 2019 2018 FY
Q4 2015 $229,028 31 Dec 2015 10-K 17 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.